0.4569
Sangamo Therapeutics Inc 주식(SGMO)의 최신 뉴스
Sangamo Therapeutics Second Quarter 2025 Earnings: Misses Expectations - Yahoo Finance
Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest
Transcript : Sangamo Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Sangamo: Q2 Earnings Snapshot - Greenwich Time
Earnings call transcript: Sangamo Therapeutics Q2 2025 earnings miss, stock drops - Investing.com Australia
Sangamo Q2 2025 slides: Neurology pipeline advances amid financial challenges - Investing.com Australia
Sangamo Therapeutics Inc (SGMO) Q2 2025 Earnings Call Highlights: Promising Fabry Disease ... By GuruFocus - Investing.com Canada
Sangamo Therapeutics Reports Strong Q2 2025 Results - TipRanks
Sangamo Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Sangamo Therapeutics Q2 Misses Revenue Estimates and Reiterates 2025 Guidance — What This Means for Its Strategic Path Forward - AInvest
Sangamo Therapeutics earnings missed by $0.06, revenue fell short of estimates - Investing.com
Sangamo Therapeutics Q2 revenue misses estimates - MarketScreener
Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2025 Financial Results - Morningstar
Sangamo Therapeutics Announces Second Quarter 2025 Earnings CallLife Science Industry News - Zenopa
Is Sangamo Therapeutics Inc. stock overvalued or undervaluedHigh-yield market plays - Jammu Links News
What are Sangamo Therapeutics Inc. company’s key revenue driversBuild a diversified portfolio for steady growth - Jammu Links News
How does Sangamo Therapeutics Inc. compare to its industry peersGet timely alerts on market opportunities - Jammu Links News
Why is Sangamo Therapeutics Inc. stock attracting strong analyst attentionGet daily updates on top-performing stocks - Jammu Links News
What institutional investors are buying Sangamo Therapeutics Inc. stockRapid growth trajectories - Jammu Links News
Does Sangamo Therapeutics Inc. stock perform well during market downturnsBuild wealth faster with consistent investment plans - Jammu Links News
Is Sangamo Therapeutics Inc. a good long term investmentBuild a portfolio with strong long-term growth - Jammu Links News
What makes Sangamo Therapeutics Inc. stock price move sharplyInvest smarter with daily market updates - Jammu Links News
When is Sangamo Therapeutics Inc. stock expected to show significant growthAccess powerful market insights for free - Jammu Links News
What drives Sangamo Therapeutics Inc. stock priceInvest smarter with expert stock picks - Jammu Links News
What are the technical indicators suggesting about Sangamo Therapeutics Inc.Free Stock Index Interpretation - Jammu Links News
Sangamo Therapeutics Announces Q2 2025 Earnings Call and Webcast - AInvest
How strong is Sangamo Therapeutics Inc. company’s balance sheetDaily Trading Strategy For Smart Trading - Jammu Links News
Has Sangamo Therapeutics Inc. formed a bullish divergenceOversold Bounce Stock Play Ideas Gain Attention - metal.it
Published on: 2025-07-30 16:12:38 - beatles.ru
Will Sangamo Therapeutics Inc. outperform the marketAI Trading Suggestions With Accuracy Focus Released - metal.it
Hunter Syndrome Treatment Market Exclusive Report with - openPR.com
How volatile is Sangamo Therapeutics Inc. stock compared to the marketAI Powered Updates From AI Tools - Jammu Links News
What is the dividend policy of Sangamo Therapeutics Inc. stockDiscover high-impact stocks for growth - Jammu Links News
What are the latest earnings results for Sangamo Therapeutics Inc.Free Stock Updates For 2025 - jammulinksnews.com
Published on: 2025-07-28 06:51:50 - Jammu Links News
Why Sangamo Therapeutics Inc. stock is on top investor watchlistsSafe and Scalable Investment Tips - metal.it
Published on: 2025-07-27 08:45:15 - metal.it
How Sangamo Therapeutics Inc. stock performs during market volatilityChart Breakout Alert - metal.it
Sangamo Therapeutics Announces Positive Phase 1/2 STAAR Study Results for Fabry Gene Therapy - MSN
자본화:
|
볼륨(24시간):